Beckman Coulter Introduces Total Laboratory Automation Solutio... - 02 May 2019 08:59

BREA, Calif., May 2, 2019 /PRNewswire-AsiaNet/ -- -- The DxA 5000 delivers rapid and consistent turnaround time, provides the industry's most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency Beckman Coulter, a global leader in clinical diagnostics, anno...

  binx health Receives CE Mark For Rapid Chlamydia And Gonorrhea... - 01 May 2019 23:00

BOSTON, May 2, 2019 /PRNewswire-AsiaNet/ -- -- Multiplex Test Panel for binx io(R) Point-of-Care Platform Positioned to Radically Reduce Time to Treatment, Expand Access to Care binx health(TM), the pioneer in anywhere care today announced that its proprietary Chlamydia and Gonorrhea (CT...

  Tessa Therapeutics, in Collaboration with Baylor College of Me... - 01 May 2019 00:00

SINGAPORE, April 30, 2019 /PRNewswire-AsiaNet/ -- - Preclinical, 'proof-of-concept' results for a novel 'all-in-one' immunotherapy for the treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-positive solid tumors - The preclinical findings support the advancement of this multimodal immu...

  RLDatix Names Jeff Surges as CEO - 30 April 2019 22:00

TORONTO, CHICAGO, and LONDON, UK, April 30, 2019 /PRNewswire-AsiaNet/ -- --A 20+ year veteran healthcare IT executive, Surges will lead the ongoing combination of RL Solutions Inc. and Datix Inc. and will drive strategic direction and growth for RLDatix moving forward. RLDatix, a leading provider of solutions that d...

  EirGenix, Inc. Enters Into Global License Agreement for the Co... - 30 April 2019 10:20

NEW TAIPEI CITY, Taiwan, April 30, 2019 /PRNewswire-AsiaNet/ -- EirGenix, Inc. announced today that it has entered into a license agreement with global generic and biosimilar drug manufacturer Sandoz AG, granting an exclusive license to Sandoz for right of commercialization of EirGenix 's breast cancer biosimi...

  BD Launches Preventing Risks of Infections and Medication Erro... - 26 April 2019 12:00

SINGAPORE, April 26, 2019 /PRNewswire-AsiaNet/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, has launched a new patient safety program for hospitals, called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME). Aimed at addressing the to...

  Emendo Biotherapeutics Enters Into Licensing Option Agreement ... - 24 April 2019 10:00

NEW YORK, April 24, 2019 /PRNewswire-AsiaNet/ -- Emendo Biotherapeutics(http://emendobio.com/) Inc today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, Emendo will receive an investment in convertible not...

  Gracell Bio Announces FasT CAR-T, a Breakthrough Technology fo... - 23 April 2019 20:08

SHANGHAI and SUZHOU, China, April 23, 2019 /PRNewswire-AsiaNet/ -- -Gracell conquers effective, low cost, and high speed manufacturing of cellular gene therapeutics Gracell Biotechnologies, Co., Ltd. ("Gracell"), an immune cell gene therapy company, announced it has developed FasT CAR-T, a revolutionary platfo...

  Health-tech AI Startup mfine Raises $17.2 Million in Series B;... - 23 April 2019 17:58

BANGALORE, India and TOKYO, April 23, 2019 /PRNewswire-AsiaNet/ -- - Investors: SBI Investment, SBI Ven Capital Pte. Ltd., Japan; BEENEXT, Singapore, Stellaris Venture Partners and Prime Venture Partners - Plans afoot to onboard over 2500 doctors from 250 hospitals and reach 150,000 consultations per m...

  Rapid Medical Raises $20 Million in New Funding to Support Cli... - 23 April 2019 11:00

YOKNEAM, Israel, April 23, 2019 /PRNewswire-AsiaNet/ -- - Funding was led by JAM Capital Partners and MicroPort Rapid Medical, a company focused on the development of interventional neurovascular devices, announced today that it has completed an oversubscribed Series C financing of $20 million....